Skip to main content

4 Result(s)

within L. Liotta Remove this filter Internal Medicine Remove this filter

and

  1. No Access

    Article

    Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?

    D Benedetti, E Tissino, C Caldana, M Dal Bo, R Bomben, D Marconi, S Ganghammer… in Leukemia (2016)

  2. No Access

    Article

    Application of molecular technologies for phosphoproteomic analysis of clinical samples

    The integration of small kinase inhibitors and monoclonal antibodies into oncological practice has opened a new paradigm for treating cancer patients. As proteins are the direct targets of the new generations ...

    M Pierobon, J Wulfkuhle, L Liotta, E Petricoin in Oncogene (2015)

  3. No Access

    Article

    Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis

    Acute myeloid leukemia (AML) primary cells express high levels of phosphorylated Akt, a master regulator of cellular functions regarded as a promising drug target. By means of reverse phase protein arrays, we ...

    J Bertacchini, M Guida, B Accordi, L Mediani, A M Martelli, P Barozzi… in Leukemia (2014)

  4. No Access

    Article

    Non-invasive monitoring and response prediction for rectal cancer undergoing neoadjuvant radiochemotherapy (RCT)

    F. M. Smith, R. B. Stephens, E. F. Gaffney, P. Crotty… in Irish Journal of Medical Science (2005)